SAM
PCVX icon

Smartleaf Asset Management’s Vaxcyte PCVX Stock Holding History

Smartleaf Asset Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.2K Hold
575
– – ﹤0.01% 1732
2026
Q1 		$31.6K Sell
575
-22
-4% -$1.19K ﹤0.01% 1712
2025
Q4 		$27.1K Buy
597
+364
+156% +$16.3K ﹤0.01% 1870
2025
Q3 		$8.07K Buy
233
+173
+288% +$5.73K ﹤0.01% 2198
2025
Q2 		$1.95K Sell
60
-200
-77% -$6.56K ﹤0.01% 2345
2025
Q1 		$18.1K Sell
260
-138
-35% -$11K ﹤0.01% 1659
2024
Q4 		$32.6K Buy
398
+260
+188% +$25.8K ﹤0.01% 1389
2024
Q3 		$15.6K Sell
138
-42
-23% -$3.79K ﹤0.01% 1494
2024
Q2 		$14.2K Buy
+180
New +$12.3K ﹤0.01% 1205

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Smartleaf Asset Management's PCVX Position: Q2 2026 in Review

Smartleaf Asset Management held its Vaxcyte (PCVX) position steady in Q2 2026 at 575 shares worth $33.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1732.

Smartleaf Asset Management first reported a position in PCVX in Q2 2024 and has held it in 9 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Smartleaf Asset Management held 575 shares of Vaxcyte worth $33.2K as of Q2 2026.
  • Smartleaf Asset Management left its Vaxcyte share count unchanged in Q2 2026.
  • Vaxcyte made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1732 holding.
  • Smartleaf Asset Management first reported a position in Vaxcyte in Q2 2024 and has held it in 9 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.